Skip to Content
Merck
  • An enantioselective approach toward 3,4-dihydroisocoumarin through the bromocyclization of styrene-type carboxylic acids.

An enantioselective approach toward 3,4-dihydroisocoumarin through the bromocyclization of styrene-type carboxylic acids.

The Journal of organic chemistry (2011-12-20)
Jie Chen, Ling Zhou, Chong Kiat Tan, Ying-Yeung Yeung
ABSTRACT

A facile and enantioselective approach toward 3,4-dihydroisocoumarin was developed. The method involved an amino-thiocarbamate catalyzed enantioselective bromocyclization of styrene-type carboxylic acids, yielding 3-bromo-3,4-dihydroisocoumarins with good yields and ee's. 3-Bromo-3,4-dihydroisocoumarins are versatile building blocks for various dihydroisocoumarin derivatives in which the Br group can readily be modified to achieve biologically important 4-O-type and 4-N-type 3,4-dihydroisocoumarin systems. In addition, studies indicated that, by refining some parameters, the synthetically useful 5-exo phthalide products could be achieved with good yields and ee's.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Dihydrocoumarin, 99%
Sigma-Aldrich
Dihydrocoumarin, ≥99%, FCC, FG